NCT03086421Active, not recruiting
Social Emotional Development in Young Children With Cancer
Source: ClinicalTrials.gov · Last updated 17 Jun 2026
Brief summary (registry, in English)
Many children with cancer are diagnosed in early childhood, and as such, will likely miss key social experiences such as participation in preschool or kindergarten, playing on playgrounds, and other normative experiences. In typically-developing children, it is known that these experiences - and the skills that are learned during them - are critical to later well-being. Very little is known about the psychological functioning of young children with cancer, as studies have predominantly focused on those who are older (at least 8 years of age). This study will explicitly assess social functioning in preschool-aged children with cancer and follow the development of their social functioning from the end of treatment into survivorship. The goals of this pilot study are to begin to assess the impact of missed early childhood social experiences, as well as the interaction with developing neurocognitive problems. PRIMARY OBJECTIVE: Explore the impact of cancer in the central nervous system on social functioning of young children (ages 4-6) after completion of therapy.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 119 (actual)
- First submitted
- 10 Mar 2017
- Start date
- 11 Jul 2017
- Primary completion date
- Dec 2026
- Lead sponsor
- St. Jude Children's Research Hospital
- Diseases
- Childhood cancers
- NCT number
- NCT03086421
What you commit to
- Study type: Observational
- Participants enrolled: 119
- From 11 Jul 2017 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Solid tumor patients who required CNS-directed therapy (e.g., radiation, intrathecal chemotherapy)
Other illness
- Diagnosis of a genetic disorder/pre-existing neurodevelopmental condition associated with neurocognitive or social impairment (e.g., autism, Neurofibromatosis Type 1 (NF1), Down syndrome)
Other
- Inability or unwillingness of research participant or legal guardian/representative to give written informed consent.
Who the study is looking for
- Primary Diagnosis of a brain or non-CNS solid tumor
- Between 4 and 6 years of age at enrollment
- Between 6 and 12 months post-therapy at the time of enrollment
- Treatment plan included chemotherapy
- English speaking
- Cognitive and language capacity to complete measures
Age in the registry: 4 years to 6 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| St. Jude Children's Research Hospital Coordinator of this site? Confirm its status | Memphis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.